Multimodal Breast Cancer Tx May Up Cytokines, Comorbidities
Breast cancer survivors treated with multimodalities have greater burden of comorbid conditions
Biosimilar Promising for ERBB2+ Breast Cancer Treatment
Equivalent response rate for women with ERBB2-positive metastatic breast cancer receiving taxanes
Announcement Training Ups HPV Vaccination for Adolescents
Training providers in announcements can increase HPV vaccination coverage for girls and boys
ASH: Lower Rate of Sickle Cell Pain Crises With Crizanlizumab
Lower rate of crises per year; longer median time to first, second crises with high-dose therapy
Thromboprophylaxis Not Effective After Knee Arthroplasty, Casting
Does not prevent venous thromboembolism after knee arthroplasty, casting of lower leg
Meds Don’t Cut Trastuzumab-Tied Left Ventricular Remodeling
However, perindopril, bisoprolol do protect against declines in LVEF in HER2-positive early breast cancer
Incidence of Hospitalization for Hypoglycemia Decreasing
Annual decrease of 8.4 percent reported; predictors of HH include age, diabetes duration, albuminuria
Dabigatran May Be Better Than Warfarin After Bleeding Episode
Resuming any anticoagulant found safer than stopping the drugs in these cases
Psilocybin Can Pull Cancer Patients Quickly Out of Despair
Hallucinogenic drug relieves depression, anxiety quickly; effect can last for months
November 2016 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for November 2016. This roundup includes the latest...
